Evaluation of the effects of curcumin in people with chronic venous insufficiency

Phase 2

• Conditions: Chronic venous insufficiency.; Cardiovascular and cerebrovascular syphilis; A52.0

• Registration Number: IRCT20220404054408N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Satisfaction with inclusion in the study
Having an age range between 30 and 60 years
Having chronic venous insufficiency class 3 and above

Exclusion Criteria

Having other vascular diseases
Having diabetes
Having autoimmune diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Wound healing. Timepoint: 6 weeks. Method of measurement: Wound length and width.;Reduce edema. Timepoint: 6 weeks later. Method of measurement: Clinical examinations by a subspecialty physician and comparison with pre-interference.;Feeling of heaviness and pain. Timepoint: 6 weeks later. Method of measurement: Clinical examinations by a subspecialty physician and comparison with pre-interference.

Secondary Outcome Measures

Name	Time	Method
Blood factors blood cell(WBC)PlateletD-dimer, Fibrinogen, Fibrinogen to albumin, ratioNeutrophil toLymphocyte ,Neutrophil, lymphocyte homocysteine. Timepoint: 6 weeks later. Method of measurement: Laboratory techniques such as diagnostic kits.